Abstract:Over the last years, new evidence has accumulated on multiple aspects of diagnosis and management of cerebral venous and dural sinus thrombosis (CVT) including identification of new risk factors, studies on interventional treatment as well as treatment with direct oral anticoagulants. Based on the GRADE questions of the European Stroke Organization guideline on this topic, the new German guideline on CVT is a consensus between expert representatives of Austria, Germany and Switzerland. New recommendations include:• CVT occurring in the first weeks after SARS-CoV-2 vaccination with vector vaccines may be associated with severe thrombocytopenia, indicating the presence of a prothrombotic immunogenic cause (Vaccine-induced immune thrombotic thrombocytopenia; VITT).• D-dimer testing to rule out CVT cannot be recommended and should therefore not be routinely performed.• Thrombophilia screening is not generally recommended in patients with CVT. It should be considered in young patients, in spontaneous CVT, in recurrent thrombosis and/or in case of a positive family history of venous thromboembolism, and if a change in therapy results from a positive finding.• Patients with CVT should preferably be treated with low molecular weight heparine (LMWH) instead of unfractionated heparine in the acute phase.• On an individual basis, endovascular recanalization in a neurointerventional center may be considered for patients who deteriorate under adequate anticoagulation.• Despite the overall low level of evidence, surgical decompression should be performed in patients with CVT, parenchymal lesions (congestive edema and/or hemorrhage) and impending incarceration to prevent death.• Following the acute phase, oral anticoagulation with direct oral anticoagulants instead of vitamin K antagonists should be given for 3 to 12 months to enhance recanalization and prevent recurrent CVT as well as extracerebral venous thrombosis.• Women with previous CVT in connection with the use of combined hormonal contraceptives or pregnancy shall refrain from continuing or restarting contraception with oestrogen-progestagen combinations due to an increased risk of recurrence if anticoagulation is no longer used.• Women with previous CVT and without contraindications should receive LMWH prophylaxis during pregnancy and for at least 6 weeks post partum.Although the level of evidence supporting these recommendations is mostly low, evidence from deep venous thrombosis as well as current clinical experience can justify the new recommendations.This article is an abridged translation of the German guideline, which is available online.

The changing face of cerebral venous sinus thrombosis-emerging new causes and treatments

Pitfalls in the Diagnosis and Initial Management of Acute Cerebral Venous Thrombosis

Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment

Update on management of cerebral venous thrombosis

Progress on Pregnancy-Associated Cerebral Venous Sinus Thrombosis

Treatment of cerebral venous thrombosis: a review

Cerebral Venous Sinus Thrombosis: Update on Diagnosis and Management

Endovascular Treatments for Cerebral Venous Sinus Thrombosis

A review of therapeutic strategies for the management of cerebral venous sinus thrombosis

Cerebral Venous Sinus Thrombosis Risk Factors

Diagnosis and treatment of cerebral venous sinus thrombosis in pregnancy and puerperium

Cerebral venous sinus thrombosis - Current updates in the Asian context

Advances in the treatment of cerebral venous sinus thrombosis

Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review

Analysis on the Early Diagnosis and Treatment of Cerebral Venous Sinus Thrombosis in 20 Cases

New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments

New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline

Challenges in Cerebral Venous Thrombosis Management—Case Reports and Short Literature Review

Advances in the Clinical Diagnosis and Treatment of Intracranial Venous Sinus Thrombosis

Comprehensive Analysis of Risk Factors and Prognostic Outcomes in Cases of Cerebral Venous and Sinus Thrombosis in a Tertiary Care Setting

Recent advance in diagnosis and treatment of cerebral venous sinus thrombosis